|
Telitacicept 160mg Clinical Trials
2 actively recruiting trials
▲ +1 trial since September 2026
Pipeline
Phase 2: 1
Top Sponsors
- Peking University People's Hospital2
Indications
- Arthritis2
- Sjögren's Disease1
- Difficult-to-Treat Rheumatoid Arthritis1
- Interstitial Lung Disease1
- Rheumatoid Arthritis1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.